PURA Leads Trend For CBD To Disrupt $39 Billion Sexual Wellness Industry
June 25 2020 - 1:56PM
InvestorsHub NewsWire
Dallas, TX
-- June 25, 2020 -- InvestorsHub NewsWire -- Puration, Inc.
(USOTC:
PURA) today announced the acquisition of a CBD infused sexual
wellness product line. The global sexual wellness market is
anticipated to reach a $39 billion value by
2024.
Sexual wellness
is the latest market to be disrupted by
CBD:
“There are so
many cannabinoid receptors in reproductive organs and sexual
tissue,” says Equinox Health Advisory Board member Pamela Peeke,
MD, assistant professor of medicine at the University of Maryland
in Baltimore. “CBD increases blood flow [to those areas], which
enhances sensitivity and promotes the body’s own natural
lubrication.” furthermore/
CBD sexual
wellness product lines are embracing diversity and
inclusivity:
“As cultural viewpoints
around sexuality, gender and relationship dynamics change, the
sexual wellness market is responding accordingly. Gen Z, in
particular, has proven to be more progressive on the topic of gender identity, compared to
millennials.” Glossy
Today’s
acquisition makes PURA’s fourth acquisition this year.
Management plans to publish a comprehensive update on the company’s
overall acquisition campaign next week on Tuesday, June 30,
2020.
PURA’s revenue
is generated today primarily through the sales of its EVERx CBD
Sports Water. PURA reported $2.7 million in annual sales last
year and $800,000 in the first quarter of 2020. In January of
this year, PURA initiated an acquisition
campaign to acquire CBD
infused beverage, edible and topical
businesses.
Forbes reports
that vertically integrated hemp and CBD companies capitalized under
$6 million are at risk of not surviving the economic conditions
resulting from COVID-19. The challenges facing such companies
creates a target rich acquisition
market.
In conjunction
with the acquisition campaign, PURA secured a $5 million investment
to fund its acquisition efforts. The acquisition today was
secured with a royalty agreement and a commitment for PURA to fund
a marketing expansion of the product line. Learn more about
PURA’s overall acquisition and expansion initiative next week on
Tuesday, June 30, 2020.
For more
information on Puration, visit https://www.purationinc.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024